Subject:
|
DCN 1: Perception and Action DCN 2: Functional Neurogenomics IGMD 3: Genomic disorders and inherited multi-system disorders NCEBP 14: Cardiovascular diseases NCMLS 6: Genetics and epigenetic pathways of disease UMCN 2.2: Vascular medicine and diabetes UMCN 3.2: Cognitive neurosciences UMCN 5.1: Genetic defects of metabolism |
Organization:
|
Pharmacology-Toxicology Psychiatry Otorhinolaryngology Internal Medicine |
Journal title:
|
Pharmacogenetics and Genomics
|
Abstract:
|
The 1976C>T polymorphism in the adenosine A2A receptor gene (ADORA2A) modulates the psychological response to administration of the adenosine receptor antagonist caffeine. We quantified the vascular response to adenosine and caffeine to determine the relevance of this variant allele in the physiological response to these agents. We selected 10 study participants with the TT genotype and 10 CC controls, matched for activities of other proteins involved in the metabolism of adenosine. The vasodilator response to the intrabrachial administration of adenosine (0.5, 1.5, 5.0, 15.0, and 50.0 microg/min/dl; venous occlusion plethysmography) was not different between the groups (P=0.4). In addition, the effect of subsequent administration of caffeine (90 microg/min/dl) was not different (P=0.7). We conclude that the 1976C>T polymorphism does not affect the vascular response to adenosine and caffeine in humans in vivo. Therefore, this polymorphism does not contribute to the variation in the effects of adenosine receptor stimulation.
|